Unknown

Dataset Information

Five-Fraction Stereotactic Radiotherapy for Brain Metastases-A Retrospective Analysis.


ABSTRACT:

Purpose

To determine the safety and outcome profile of five-fraction stereotactic radiotherapy (FSRT) for brain metastases (BM), either as a definitive or adjuvant treatment.

Methods

We assessed clinical data of patients receiving five fractions of 7 Gy each (cumulative physical dose of 35 Gy) to BM or surgical cavities. The primary endpoints were toxicity and radiation necrosis (RN) rates. Secondary endpoints were 1-year cumulative local control rate (LCR) and estimated overall survival (OS).

Results

A total of 36 eligible patients receiving FSRT to a total of 49 targets were identified and included. The median follow up was 9 (1.1-56.2) months. The median age was 64.5 (34-92) years, the median ECOG score was 1, and the median Diagnostic-Specific Graded Prognostic As

SUBMITTER: Layer JP 

PROVIDER: S-EPMC9955428 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature